Medtronic · 20 hours ago
Associate Cardiac Rhythm Management Clinical Specialist
United States
Full-time
Remote
New Grad, Entry Level
$65K/yr - $70K/yrMedtronic is a global leader in healthcare technology committed to alleviating pain and restoring health. They are seeking an Associate Cardiac Rhythm Management Clinical Specialist to drive to multiple accounts within their territory, providing support and expertise in cardiac rhythm management products.
BiotechnologyMedical DeviceArtificial Intelligence (AI)HealthcareHealth CareHealth Diagnostics
Responsibilities
Drive to multiple accounts throughout the region
Provide support and expertise in cardiac rhythm management products
Qualification
Required
A valid driver's license is essential for this role
The candidate hired will be required to reside within the territory and drive to multiple accounts throughout the region
Benefits
Health, Dental and vision insurance
Health Savings Account
Healthcare Flexible Spending Account
Life insurance
Long-term disability leave
Dependent daycare spending account
Tuition assistance/reimbursement
Simple Steps (global well-being program)
Incentive plans
401(k) plan plus employer contribution and match
Short-term disability
Paid time off
Paid holidays
Employee Stock Purchase Plan
Employee Assistance Program
Non-qualified Retirement Plan Supplement (subject to IRS earning minimums)
Capital Accumulation Plan (available to Vice Presidents and above, or subject to IRS earning minimums)
Company
Medtronic
Medtronic is a healthcare technology company that designs and develops AI-based products and solutions for the medical industry.
Founded in 1949
10001+ employees
H1B Sponsorship
Medtronic has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (349)
2024 (387)
2023 (291)
2022 (310)
2021 (300)
2020 (261)
Funding
Current Stage
Public CompanyTotal Funding
$18.17BKey Investors
NHS EnglandBlackstone Life SciencesTrade Capital Funding
2025-09-15Post Ipo Debt· $1.76B
2024-05-29Post Ipo Debt· $3.24B
2023-03-23Post Ipo Debt· $2B
Leadership Team
Geoffrey Martha
CEO and Chairman Of The Board Of Directors
Linnea Burman
SVP & President, Neurovascular
Recent News
Orange County Business Journal
2026-02-10
2026-02-07
Company data provided by crunchbase